Description: For we want more and more people to have access to biotherapeutics: Wherever they are in the world. At the lowest possible price. At the highest possible…
quality (7181) world (4500) people (4431) access (2065) price (2011) want (807) highest (150) possible (128) lowest (50) biotherapeutics (14)
UNCODE.initHeader(); Bioeq GmbH A Formycon Group Company
Since the acquisition in May 2022, Bioeq GmbH is a part of the Formycon Group and continues to be the sponsor of the ongoing clinical trials for Formycon’s biosimilar candidates.
The former Bioeq employees have meanwhile joined #TeamFormycon and contribute their expertise in clinical development, regulatory affairs, business development, commercial affairs, IP as well as project management to Formycon’s strengthened development organization .